vimarsana.com

Latest Breaking News On - Woolcock institute - Page 1 : vimarsana.com

Dr Ron Grunstein Discusses Findings on Investigational Orexin Agonist in Patients With Narcolepsy

Ron Grunstein, MD, PhD, head of sleep and circadian research, Woolcock Institute of Medical Research, shares findings from a phase 1b study on the use of a novel orexin agonist in patients with narcolepsy type 1.

Tirzepatide Significantly Reduces Weight in Patients with OSA

New analysis from SURMOUNT-1 support the use of GLP-1/GIP agonist tirzepatide to reduce weight in patients with OSA and obesity/overweight.

Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.